Literature DB >> 1683981

Intraperitoneal local anaesthetic for shoulder pain after day-case laparoscopy.

P Narchi1, D Benhamou, H Fernandez.   

Abstract

Laparoscopy is frequently associated with postoperative shoulder pain that may last several days. We have assessed the analgesic effect of intraperitoneal local anaesthetics during day-case diagnostic laparoscopy. 80 young women were randomly assigned to one of four groups of 20 patients each: group 1, no peritoneal administration; group 2, 80 ml saline injected under direct vision in the right subdiaphragmatic area at the start of the procedure; group 3, 80 ml 0.5% lignocaine with adrenaline (320,000 dilution); group 4, 0.125% bupivacaine with adrenaline (800,000 dilution). Scapular pain was assessed with a visual analogue pain scale, and information about nausea, vomiting, abdominal pain, and analgesic requirements during the first 48 h was sought. Both local anaesthetics were more effective in reducing postoperative shoulder pain than either control or saline. Analgesic requirements were greater in the non-treatment groups than in the local anaesthetic groups. Intraperitoneal local anaesthetic administration during laparoscopy is both a non-invasive and an efficient method of reducing the intensity of scapular pain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683981     DOI: 10.1016/0140-6736(91)92384-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

1.  Local anesthesia use for laparoscopic cholecystectomy.

Authors:  Aydin Inan; Meral Sen; Cenap Dener
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

2.  A placebo-controlled comparison of bupivacaine and ropivacaine instillation for preventing postoperative pain after laparoscopic cholecystectomy.

Authors:  Canan Kucuk; Nihal Kadiogullari; Ozgur Canoler; Serpil Savli
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

Review 3.  Regional anesthesia for laparoscopic surgery: a narrative review.

Authors:  George Vretzakis; Metaxia Bareka; Diamanto Aretha; Menelaos Karanikolas
Journal:  J Anesth       Date:  2013-11-07       Impact factor: 2.078

4.  Combined low pressure pneumoperitoneum and intraperitoneal infusion of normal saline for reducing shoulder tip pain following laparoscopic cholecystectomy.

Authors:  M Emad Esmat; Magdy M A Elsebae; Magid M A Nasr; Sameh B Elsebaie
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

Review 5.  Use of nerve block techniques for postoperative analgesia.

Authors:  Per H Rosenberg
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

6.  A double-blinded evaluation of intraperitoneal bupivacaine vs saline for the reduction of postoperative pain and nausea after laparoscopic cholecystectomy.

Authors:  J W Szem; L Hydo; P S Barie
Journal:  Surg Endosc       Date:  1996-01       Impact factor: 4.584

7.  Evaluation of the effect of intrathecal clonidine to decrease shoulder tip pain in laparoscopy under spinal anaesthesia.

Authors:  Poonam S Ghodki; Shalini P Sardesai; Shalini K Thombre
Journal:  Indian J Anaesth       Date:  2010-05

8.  Pain after laparoscopic cholecystectomy. Intensity and localization of pain and analysis of predictors in preoperative symptoms and intraoperative events.

Authors:  B M Ure; H Troidl; W Spangenberger; A Dietrich; R Lefering; E Neugebauer
Journal:  Surg Endosc       Date:  1994-02       Impact factor: 4.584

9.  A comparison of intravenous-based and epidural-based techniques for anesthesia and postoperative analgesia in elderly patients undergoing laparoscopic cholecystectomy.

Authors:  Kohki Nishikawa; Saori Kimura; Yuki Shimodate; Motohiko Igarashi; Akiyoshi Namiki
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

10.  Laparoscopic cholecystectomy as a day surgery procedure: implementation and audit of 136 consecutive cases in a university hospital.

Authors:  Henri Vuilleumier; Nermin Halkic
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.